Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia G Vallianou

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Journal of Chemotherapy (Florence, Italy)|January 17, 2019
Microbiota and cancer: an updateNatalia G Vallianou, Fotini Tzortzatou-Stathopoulou
Biomolecules|November 27, 2025
Decoding the Spectrum of Anorexia Nervosa: Clinical Impact, Molecular Insights, and Therapeutic PerspectivesDimitris C Kounatidis, Natalia G Vallianou
Metabolism Open|April 29, 2021
Prediabetes screening: Questionable benefits in the golden yearsDimitrios Tsilingiris, Natalia G Vallianou, Maria Dalamaga
Diabetes Research and Clinical Practice|October 21, 2018
Microbiome and diabetes: Where are we now?Natalia G Vallianou, Theodora Stratigou, Stylianos Tsagarakis
The Review of Diabetic Studies : RDS|May 21, 2014
Metformin and cancerNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
The Review of Diabetic Studies : RDS|May 21, 2014
Resveratrol and diabetesNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 7, 2019
Microbiome and hypertension: where are we now?Natalia G Vallianou, Eleni Geladari, Dimitris Kounatidis
Clinical Nephrology|February 9, 2017
Sodium glucose co-transporter 2 inhibitors and their nephroprotective potential
Natalia G Vallianou, Kyriakos Trigkidis, Christos Kazazis
Anti-Cancer Agents in Medicinal Chemistry|September 13, 2018
Silimarin and CancerChristina Liakopoulou, Christos Kazazis, Natalia G Vallianou
Hormones (Athens, Greece)|February 6, 2019
Metformin and gut microbiota: their interactions and their impact on diabetesNatalia G Vallianou, Theodora Stratigou, Stylianos Tsagarakis
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal of Chemotherapy (Florence, Italy)|January 17, 2019
Microbiota and cancer: an updateNatalia G Vallianou, Fotini Tzortzatou-Stathopoulou
Biomolecules|November 27, 2025
Decoding the Spectrum of Anorexia Nervosa: Clinical Impact, Molecular Insights, and Therapeutic PerspectivesDimitris C Kounatidis, Natalia G Vallianou
Metabolism Open|April 29, 2021
Prediabetes screening: Questionable benefits in the golden yearsDimitrios Tsilingiris, Natalia G Vallianou, Maria Dalamaga
Diabetes Research and Clinical Practice|October 21, 2018
Microbiome and diabetes: Where are we now?Natalia G Vallianou, Theodora Stratigou, Stylianos Tsagarakis
The Review of Diabetic Studies : RDS|May 21, 2014
Metformin and cancerNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
The Review of Diabetic Studies : RDS|May 21, 2014
Resveratrol and diabetesNatalia G Vallianou, Angelos Evangelopoulos, Christos Kazazis
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 7, 2019
Microbiome and hypertension: where are we now?Natalia G Vallianou, Eleni Geladari, Dimitris Kounatidis
Clinical Nephrology|February 9, 2017
Sodium glucose co-transporter 2 inhibitors and their nephroprotective potential
Natalia G Vallianou, Kyriakos Trigkidis, Christos Kazazis
Anti-Cancer Agents in Medicinal Chemistry|September 13, 2018
Silimarin and CancerChristina Liakopoulou, Christos Kazazis, Natalia G Vallianou
Hormones (Athens, Greece)|February 6, 2019
Metformin and gut microbiota: their interactions and their impact on diabetesNatalia G Vallianou, Theodora Stratigou, Stylianos Tsagarakis
Pageof 10